ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

No reading has been made of this study yet; what is shown is how the rules link it today.

4 links0 made here, not in the record6 judgments1 judge (the rules as one: Rule based)1 record change seen
Rule basedRecord updated on ClinicalTrials.gov
Sep 28Oct 5Oct 12Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT06846515Phase 3 Evaluation ofEfficacy and Safety ofAR882 in Gout Patients(AR882-301)Arthrosi TherapeuticsPhase 3 · completedRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Sep 28 · ClinicalTrials.gov record · Version of 2026-09-28Version of 2026-09-28CONDITIONSGoutThe registry's MeSH filing›Nov 14 · Rule based · Wider: a narrower term is filedWider: a narrower term is filedArthritis, GoutyThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termAs of now · Rule based · Main conditionMain conditionHyperuricemiaThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termDRUGSAR882Entry “AR882 50 mg”, read by our name…›As of now · Rule based · TestedAs of now · Rule based · TestedTested

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Gout

From the registry record1 judgment on this link
Kind of condition link, from the registry to what was judged
RegistryGout, as filedthe registry files the study under it
→judged

All judgments on this study

WhenLinkJudgeDecisionState
Sep 28The record itselfClinicalTrials.gov recordVersion of 2026-09-28Record change
Nov 14GoutRule based · condition-kind ruleWider: a narrower term is filedCurrent
Nov 14Arthritis, GoutyRule based · condition-kind ruleFinest filed termCurrent
Nov 14HyperuricemiaRule based · condition-kind ruleFinest filed termCurrent
As of nowArthritis, GoutyRule based · main-condition ruleMain conditionCurrent
As of nowAR882Rule based · role ruleTestedCurrent
As of nowAR882Rule based · role ruleTestedCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.

How a condition link is counted

For each condition a study is filed under: whether it is the study's own condition at the finest the study states it, a wider one, a general category, or filed by mistake; and whether it is the main condition, a setting the study names, or only how it was filed.

A decision on file for one study overrides it, with who made it and when.